machineMD
Innovating at the intersection of neuroscience and ophthalmology
HQRemote
Team Size30
Open JobsUnknown
Total Funding-
Latest FundraiseUnknown
Innovating at the intersection of neuroscience and ophthalmology
Headquarters: Bern, Switzerland
Founded: December 2019
Employees: 30
Tech focus: Virtual reality, artificial intelligence, eye/pupil-based neuro‑ophthalmology
Funding highlights: Seed CHF 3.2M (Sep 2022, lead: Guido Fluri Foundation); Pre-Series A strategic investment led by Topcon Healthcare (Mar 2025, amount undisclosed)
CEO: Dominic Senn
Neurodiagnostics; neuro‑ophthalmology; early detection of brain and neurological disorders.
2019
Medical devices; Digital health
CHF 1.4M
Closed as a CHF 1.4M convertible loan; investors described as physicians, business angels, and the Canton of Bern's location promotion.
Recipient of a User‑Centred HealthTech grant (part of a CHF 80,000 call awarded across five projects).
CHF 1.25M
Innosuisse project funding referenced in the seed‑round announcement (non‑dilutive support to develop a prototype).
CHF 3.2M
Seed round reported as oversubscribed by 50%; included conversion of a CHF 1.2M convertible note into equity.
Topcon Healthcare announced as lead investor in a pre‑Series A strategic investment; amount not disclosed.
“Mix of foundation-led seed investment, strategic corporate investor participation (Topcon Healthcare), public/non‑dilutive support (Innosuisse and grants), and business angels/physician investors.”